A Stepwise Targeting and Antibacterial Strategy by Leukocyte Membrane-Based Conjugated Oligomer Nanoparticles

ACS Appl Bio Mater. 2023 Jun 19;6(6):2487-2495. doi: 10.1021/acsabm.3c00277. Epub 2023 Jun 8.

Abstract

Bacterial infection poses an enormous threat to human life and health. The inability of drugs to be effectively delivered to the site of infection and the development of bacterial resistance make the treatment process more difficult. Herein, a stepwise targeted biomimetic nanoparticle (NPs@M-P) with inflammatory tendency and Gram-negative bacterial targeting was designed, which can achieve efficient antibacterial activity under near-infrared triggering. Leukocyte membranes and targeted molecules (PMB) are used to deliver NPs to the surface of Gram-negative bacteria. The heat and ROS released by NPs@M-P can efficiently kill Gram-negative bacteria under low-power near-infrared light. Thus, this multimodal combination therapy strategy has broad promise in fighting bacterial infection and avoiding drug resistance.

Keywords: Gram-negative bacteria; antibacterial; biomimetic nanoparticles; near-infrared light; stepwise targeting.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Gram-Negative Bacteria
  • Humans
  • Nanoparticles* / therapeutic use

Substances

  • Anti-Bacterial Agents